Company Prana Biotechnology Limited Nasdaq
Equities
US7397272045
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 63 | 01/17/01 |
Geoffrey Kempler
FOU | Founder | 69 | 11/97/11 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 01/14/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Kempler
FOU | Founder | 69 | 11/97/11 |
Peter Marks
BRD | Director/Board Member | 68 | 29/05/29 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 08/11/08 |
Brian Meltzer
BRD | Director/Board Member | 70 | 09/99/09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,802,360,380 | 2,436,015,074 ( 86.93 %) | 0 | 86.93 % |
Company contact information
Alterity Therapeutics Ltd.
350 Collins Street Level 14
3000, Melbourne
+61 3 9349 4906
http://www.alteritytherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |